You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-PCSK7 antibody - Aminoterminal end (ab39874)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-PCSK7 antibody - Aminoterminal end
See all PCSK7 products (5) ...

Description

Rabbit polyclonal to PCSK7 - Aminoterminal end

Specificity

ab39874 recognises the Amino end of mature enzyme PCSK7.

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide corresponding to the amino end of activated Human PCSK7.

(Peptide available as ab41415.)

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol, PBS, 500mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - PCSK7 antibody - Aminoterminal end (ab39874)Western blot - PCSK7 antibody - Aminoterminal end (ab39874) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab39874 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. The message for PC7-A encodes a 591 amino acid protein with a predicted mass of 64.4 kDa, and a pI of 5.9. The PC7-B protein has an apparent mass of 101 kDa on reduced SDS PAGE gels, and is processed to a secreted 89 kDa form. Predicted molecular weight: 86 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Target

Relevance

PC7 was the first described in the rat pituitary, and found to be expressed in many tissues including brain, adrenal gland, gut, ovary, testis, kidney, liver lung, thyroid and pancreas. A literature alias is C8 or PC8 . Two splice variants are reported; a 591 amino acid sequence (PC7A) and a 785 amino acid membrane-associated form (PC7B). The longer form is thought to be bound in the Golgi, and the shorter form secreted through dense core secretory granules. PC7 has been shown to cleave parathyroid hormone and Tumor Necrosis Factor aloha converting enzyme (TACE, ADAM17). Like furin, PC1, PC2 and PACE4, PC7 is a serine proteinase that cleaves after pairs of basic amino acids, but with some differences in substrate specificity and distribution. The catalytic domain has homology to other PC enzymes, the prohormone convertase family initially discovered for their role in processing POMC, insulin and other pro-hormones, and later found to process a wider range of precursor proteins. Some have renamed the prohormone convertases as proprotein convertases, and another group has renamed the entire family with a uniform nomenclature of SPCs (subtilisin-like proprotein convertases), with PC7 getting the SPC7 moniker. PC7 structure contains a propeptide domain, a catalytic domain and an RGD containing cysteine-rich domain (homo-B). The longer sequence contains an extended cysteine-rich domain. The PCs have an RxxR consensus cleavage requirement, and the propeptide is separated from the mature protein by just such a sequence. After cleavage of the propeptide domain, PC7 becomes a two-chain form, and the propeptide piece is released after a second internal cleavage. PC7A resides mainly in the dense core secretory vesicles and the TGN, and is cycled to the surface, with some of the PC7 being secreted from the cells. PC7 has been reported to be elevated in tumor cell lines and to increase tumor progression. The message for PC7A encodes a 591 amino acid protein with a predicted mass of 64.4 kDa, and a pI of 5.9. The PC7B protein has an apparent mass of 101 kDa on reduced SDS PAGE gels, and is processed to a secreted 89 kDa form.

Cellular localization

The longer form is thought to be bound in the Golgi, and the shorter form secreted through dense core secretory granules.

Alternative names

  • LPC antibody
  • Lymphoma proprotein convertase antibody
  • PC7 antibody
  • PC8 antibody
  • Prohormone convertase 8 antibody
  • Proprotein convertase PC7 antibody
  • Proprotein convertase subtilisin/kexin type 7 antibody
  • SPC7 antibody
see all

Anti-PCSK7 antibody - Aminoterminal end images:

  Western blot - PCSK7 antibody - Aminoterminal end (ab39874)

Western blot - PCSK7 antibody - Aminoterminal end (ab39874)

All lanes : Anti-PCSK7 antibody - Aminoterminal end (ab39874) at 1/1000 dilution

Lane 1 : Recombinant human PC7 at 0.05 µg
Lane 2 : Recombinant human PC7 at 0.01 µg
Lane 3 : Recombinant human PC7 at 0.001 µg


Predicted band size : 86 kDa
Observed band size : 89 kDa (why is the actual band size different from the predicted?)

References for Anti-PCSK7 antibody - Aminoterminal end (ab39874)

ab39874 has not yet been referenced specifically in any publications.

Publishing research using ab39874? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"